力诺药包股价涨5.1%，圆信永丰基金旗下1只基金位居十大流通股东，持有162万股浮盈赚取142.56万元

Core Viewpoint - Linuo Pharmaceutical Packaging Co., Ltd. has seen a 5.1% increase in stock price, reaching 18.12 CNY per share, with a total market capitalization of 4.408 billion CNY as of February 24 [1] Group 1: Company Overview - Linuo Pharmaceutical Packaging was established on March 1, 2002, and went public on November 11, 2021 [1] - The company specializes in the research, production, and sales of specialty glass, focusing on the development and application of borosilicate glass [1] - The revenue composition of the company includes 57.02% from heat-resistant glass, 40.74% from pharmaceutical glass, and 2.24% from material sales and others [1] Group 2: Shareholder Information - YX Fund's YX Healthcare A (006274) has entered the top ten circulating shareholders of Linuo Pharmaceutical, holding 1.62 million shares, which is 0.68% of the circulating shares [2] - The fund has achieved a year-to-date return of 7.94% and a one-year return of 35.34% [2] - The fund manager, Xiao Shiyuan, has a tenure of 8 years and 251 days, with a total fund asset size of 2.069 billion CNY [2][4] Group 3: Fund Holdings - YX Fund's YX聚优 A (010469) has reduced its holdings in Linuo Pharmaceutical by 77,400 shares, now holding 1.1776 million shares, which constitutes 2.99% of the fund's net value [3] - The fund has a year-to-date return of 6.25% and a one-year return of 34.56% [3] - The fund manager, Xiao Shiyuan, has a total asset size of 2.069 billion CNY [4]